BioCentriq will be attending the 7th CAR-TCR Summit Europe. Join David Smith, our VP of Development for the presentation of the first public CAR-T expansion data from BioCentriq’s collaboration with Terumo Blood and Cell Technologies.
The data will demonstrate for the first time publicly, the ability to rapidly produce CAR-T cells using protocols developed by Terumo BCT for its Quantum Flex and Finia® Fill and Finish System platforms in tandem with BioCentriq’s LEAP™ Advanced Therapy Platform.
Please contact us to schedule a meeting with David.